Skip to main content
Article thumbnail
Location of Repository

Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice

By A M Neyrinck, V F Van Hée, N Piront, F De Backer, O Toussaint, P D Cani and N M Delzenne
Topics: Original Article
Publisher: Nature Publishing Group
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2009). A core gut microbiome in obese and lean twins. Nature
    2. (2010). A human gut microbial gene catalogue established by metagenomic sequencing.
    3. (2005). A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care
    4. (2011). Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol
    5. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut
    6. (2009). Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem.
    7. (2010). Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta
    8. (2008). Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.
    9. (2008). Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe
    10. (2005). Dietary fiber and body weight. Nutrition
    11. (2012). Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitinglucan fiber improves host metabolic alterations induced by high-fat diet in mice.
    12. (2008). Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.
    13. (2010). Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev
    14. (2008). Early differences in fecal microbiota composition in children may predict overweight.
    15. (2010). Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
    16. (2006). Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity
    17. (1972). Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem
    18. (2009). Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J Agric Food Chem
    19. (2009). Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal.
    20. (2002). Impact of whole wheat flour and its milling fractions on the cecal fermentations and the plasma and liver lipids in rats. J Agric Food Chem
    21. (2006). Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like Peptide 1 receptor. Diabetes
    22. (2011). Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
    23. (2004). Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats.
    24. (2010). Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice.
    25. (2005). Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol
    26. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes
    27. (2006). Microbial ecology: human gut microbes associated with obesity. Nature
    28. (2011). Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact
    29. (2010). Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol
    30. (2010). Obesity and the human microbiome. Curr Opin Gastroenterol
    31. (2009). Obesity and the microbiota. Gastroenterology
    32. (2005). Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res
    33. (2010). Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Curr Opin Clin Nutr Metab Care
    34. (2012). Prebiotic and other health-related effects of cereal-derived arabinoxylans, Prebiotic effects of arabinoxylan oligosaccharides
    35. (2011). Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, roseburia and bacteroides/prevotella in diet-induced obese mice. PLoS One
    36. (2010). Prebiotic effects: metabolic and health benefits.
    37. (2007). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia
    38. (2008). Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties in rats.
    39. (2008). TaqMan low density array is roughly right for gene expression quantificationi nc o l o r e c t a lc a n c e r .Clin Chim Acta
    40. (2011). Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol
    41. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol
    42. The gut microbiome as therapeutic target.
    43. Whole wheat and triticale flours with differing viscosities stimulate cecal fermentations and lower plasma and hepatic lipids in rats. JN u t r2001; 131:

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.